Dimensional Fund Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.9M Sell
648,336
-123,967
-16% -$3.43M ﹤0.01% 2022
2025
Q1
$17.2M Buy
772,303
+696
+0.1% +$15.5K ﹤0.01% 2011
2024
Q4
$15.3M Buy
771,607
+29,300
+4% +$580K ﹤0.01% 2125
2024
Q3
$18.6M Buy
742,307
+78,267
+12% +$1.96M ﹤0.01% 2036
2024
Q2
$12.4M Buy
664,040
+157,741
+31% +$2.95M ﹤0.01% 2166
2024
Q1
$9.99M Buy
506,299
+156,546
+45% +$3.09M ﹤0.01% 2310
2023
Q4
$6.13M Sell
349,753
-23,968
-6% -$420K ﹤0.01% 2502
2023
Q3
$6.49M Sell
373,721
-1,388
-0.4% -$24.1K ﹤0.01% 2439
2023
Q2
$5.28M Sell
375,109
-2,149
-0.6% -$30.3K ﹤0.01% 2505
2023
Q1
$4.06M Sell
377,258
-15,533
-4% -$167K ﹤0.01% 2545
2022
Q4
$5.88K Sell
392,791
-675
-0.2% -$10 ﹤0.01% 2395
2022
Q3
$5.05M Sell
393,466
-13,681
-3% -$176K ﹤0.01% 2422
2022
Q2
$3.95M Buy
407,147
+46,207
+13% +$448K ﹤0.01% 2517
2022
Q1
$3.59M Buy
360,940
+201,622
+127% +$2M ﹤0.01% 2635
2021
Q4
$1.88M Buy
159,318
+25,031
+19% +$295K ﹤0.01% 2862
2021
Q3
$1.53M Sell
134,287
-193,927
-59% -$2.21M ﹤0.01% 2925
2021
Q2
$4.57M Buy
328,214
+90,167
+38% +$1.26M ﹤0.01% 2638
2021
Q1
$4.41M Buy
238,047
+163,191
+218% +$3.02M ﹤0.01% 2625
2020
Q4
$1.32M Buy
74,856
+4,609
+7% +$81.5K ﹤0.01% 2917
2020
Q3
$1.08M Buy
70,247
+5,167
+8% +$79.1K ﹤0.01% 2911
2020
Q2
$1.66M Sell
65,080
-791
-1% -$20.2K ﹤0.01% 2816
2020
Q1
$1.02M Buy
65,871
+39,181
+147% +$604K ﹤0.01% 2887
2019
Q4
$295K Buy
+26,690
New +$295K ﹤0.01% 3215